Jiro Morimoto
Saitama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Effect of administration and withdrawal of the sodium-glucose cotransporter 2 inhibitor, tofogliflozin, on renal protection in individuals with type 2 diabetes mellitus and diabetic nephropathy: A multicenter, single-arm study (RESTORE-nephropathy study).
Journal: Journal of diabetes investigation
Published: November 22, 2024
Current clinical state of type 1 diabetes in Saitama prefecture.
Journal: Diabetology international
Published: September 13, 2021
Time in range correlates glycated albumin measured immediately after 2 weeks of continuous glucose monitoring.
Journal: Journal of diabetes and its complications
Published: February 25, 2021
Efficacy and safety of liraglutide monotherapy compared with metformin in Japanese overweight/obese patients with type 2 diabetes.
Journal: Endocrine journal
Published: March 06, 2015
Glycated albumin is not significantly correlated with body mass index in patients with acute-onset type 1 diabetes.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: June 12, 2014
Effects of concomitant drugs on sitagliptin-mediated improvement in glycemic control in Japanese patients with type 2 diabetes.
Journal: Primary care diabetes
Published: December 16, 2013
Slowly progressive type 1 diabetes treated with metformin for five years after onset.
Journal: Internal medicine (Tokyo, Japan)
Published: December 03, 2013
Time-course changes in nerve conduction velocity (NCV) in type 2 diabetes.
Journal: Journal of diabetes and its complications
Published: January 21, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026